BeStock  
Stocks › Medical Devices › CBLL

Ceribell CBLL

US equityMarket cap rank #3196Medical DevicesBrain-Computer Interface
$26.59 +$0.58 (+2.23%)
Market closed · Nov 7, 6:40 am ET · Last extended-hours $26.59 0.00%
Open$25.67
Prev close$26.01
Day range$24.87 – $26.79
Volume436.4K
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bullish

4 bullish · 3 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-0.9%BearishTrading below the 20-day average of $26.84
Price vs 50-day average+5.3%BullishTrading above the 50-day average of $25.25
Price vs 200-day average+27.2%BullishTrading above the 200-day average of $20.90
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)51.9BullishMomentum leans positive
MACD (12,26,9)0.59BearishMACD line is below its signal line
Bollinger band position42%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$26.84-0.9%
50-day SMA$25.25+5.3%
200-day SMA$20.90+27.2%

Recent price levels

LevelPrice
20-day high$28.89
20-day low$21.86
60-day high$28.89
60-day low$21.86
Upper Bollinger band$28.53
Lower Bollinger band$25.16

The 50-day average is currently 20.8% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility58.8%
Average true range6.61% of price
Max drawdown (1y)-30.5%
Volume (10d vs 90d)1.70x

Discussion

No comments yet — be the first to weigh in on CBLL.

Leave a comment

Scroll to Top